Retargeting mobile group II introns to repair mutant genes

This publication has 23 references indexed in Scilit:

• Endothelial targeting of the Sleeping Beauty transposon within lung
  Molecular Therapy, 2004
• Activation of the T-Cell OncogeneLMO2after Gene Therapy for X-Linked Severe Combined Immunodeficiency
  New England Journal of Medicine, 2004
• Analysis of the stimulatory effect of splicing on mRNA production and utilization in mammalian cells
  RNA, 2003
• A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
  New England Journal of Medicine, 2003
• Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria
  Nature Biotechnology, 2001
• Expression of ΔF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR
  Gene Therapy, 2001
• Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics
  Journal of Clinical Investigation, 2000
• One binding site determines sequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity
  Cell, 1986
• Coupling of Tetrahymena Ribosomal RNA Splicing to β-Galactosidase Expression in Escherichia coli
  Science, 1985
• The tetrahymena rRNA intron self-splices in E. coli: In vivo evidence for the importance of key base-paired regions of RNA for RNA enzyme function
  Cell, 1985